Neuroderm reformulates and/or co-formulates well established drugs to enable new routes of administration that achieve a better, or a new, clinical effect. The company focuses on CNS diseases and its leading products include novel dermal delivery for the treatment of Parkinson ’s disease, ADD/ADHD and other CNS disorders and diseases.
Terms of Use & Privacy Policy Copyright NeuroDerm © 2013 All rights reserved.
overview management board of directors advisors